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Abstract
Chlamydia trachomatis (Ct) is the most reported sexually transmitted infection
in the United States with a major cause of infertility, pelvic inflammatory dis-
ease, and ectopic pregnancy among women. Despite decades of screening women
for Ct, rates increase among young African Americans (AA). We create and an-
alyze an heterosexual agent-based network model to help understand the spread
of Ct. We calibrate the model parameters to agree with survey data showing
Ct prevalence of 12% of the women and 10% of the men in the 15− 25 year-old
AA in New Orleans, Louisiana. Our model accounts for both long-term and
casual partnerships. The network captures the assortative mixing of individuals
by preserving the joint-degree distributions observed in the data. We compare
the effectiveness of intervention strategies based on randomly screening men,
notifying partners of infected people, which includes partner treatment, partner
screening, and rescreening for infection. We compare the difference between
treating partners of an infected person both with and without testing them.
We observe that although increased Ct screening, rescreening and treating most
of the partners of infected people will reduce the prevalence, these mitigations
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alone are not sufficient to control the epidemic. The current practice is to treat
the partners of an infected individual, without first testing them for infection.
The model predicts that if a sufficient number of the partners of all infected
people are tested and treated, then there is a threshold condition where the
epidemic can be mitigated. This threshold results from the expanded treatment
network created by treating the partners of the infected partners of an individ-
ual. Although these conclusions can help design future Ct mitigation studies,
we caution the reader that these conclusions are for the mathematical model,
not the real world, and are contingent on the validity of the model assumptions.
Keywords: Chlamydia; Agent based Network Model; Screening; Partner
Notification; Sexual Network
1. Introduction
Chlamydia trachomatis (Ct) is the most commonly notified bacterial sexually
transmitted infection (STI) in the United States, with over 1.8 million cases each
year [1]. It is a major cause of infertility, pelvic inflammatory disease (PID),
and ectopic pregnancy among women [2, 3, 4, 5, 6, 7, 8], and has been associated
with increased HIV acquisition [2, 4, 7, 8, 6]. Untreated, an estimated 14.8% of
women with Ct will develop PID [9, 10], and 6% will have tubal infertility [7].
In southern US cities, including New Orleans, there is an ongoing epidemic of
Ct in young African American (AA) adults. A pilot study in this community
[11] found an average of 1.5 sexual partners per person per three months, a
relatively high turnover in sexual partners, and approximately 11% prevalence
of Ct infection. The high prevalence and high turnover stress the need for more
effective mitigation efforts to bring the epidemic under control.
Further complicating the issue, some studies show that about 70%− 95% of
women and 90% of men infected with Ct are asymptomatic and still transmit the
infection to others [12, 13]. When Ct prevalence is high, regular screening is a
practical approach to identify and treat infected individuals. The US Preventive
Services Task Force (USPSTF) recommends that sexually active women younger
2
than 25 years old, or older if they have multiple sexual partners, be screened for
Ct as part of their physical exam [14]. However, untreated men may serve as a
reservoir and reinfect treated women . We investigate the impact of increased Ct
screening of men in high prevalence areas on the disease prevalence. Typically,
when someone is found to be infected, they are urged to encourage their sexual
partners to be tested for infection. Sometimes the partners are treated without
first being tested for infection. If a partner is tested for infection and found to
be infected, then their partners can be notified and treated, identifying a chain
of high-risk individuals who might be spreading Ct.
Transmission-based mathematical models can help the public health com-
munity to understand and to anticipate the spread of diseases in different popu-
lations and to evaluate the potential effectiveness of approaches for bringing the
epidemic under the control [15]. These models create frameworks that capture
the underlying Ct epidemiology and the heterosexual social structure underlying
the transmission dynamics. Compartmental [16, 17, 18, 19, 20, 21, 15, 22] and
agent-based [23, 24, 25, 26, 27, 28] mathematical models can help researchers
to understand the transmission dynamics, and to analyze the efficiency and
cost-benefit analysis of different intervention scenarios to control Ct infection in
different regions.
Althaus et al. [16] and Clarke et al. [22] used two different compartmen-
tal approaches to test the impact of screening programs on Ct infection, and
both admitted that prevalence of Ct is not effectively sensitive to this program
alone. Althaus et al. [16] identified the time to recovery from infection, and the
duration of the asymptomatic period, as the two of the most essential model
parameters governing the disease prevalence. When the underlying model is not
static, Clarke et al. [22] demonstrated that random screening, if coupled with
partner notification, is a cost-effective mitigation approach.
The efficiency of screening and partner notification strategies highly depends
on the constructed model; that is, the result of one strategy can be different in
the individual and population-level models [29]. Kretzschmar et al. [30] used
a stochastic network model based on pair formation and separation process to
3
evaluate different screening and partner referral methodologies in controlling
STIs such as Ct. Their results for Ct show that treating at least 50% of part-
ners of infected people can reduce the prevalence to a low level. They observed
that the effectiveness of screening depends on the age, gender, and other char-
acteristics of the targeted group.
The heterosexual networks impacts the transmission dynamic and the ef-
fectiveness of different intervention approaches via capturing complex heteroge-
neous and biased mixing and sexual behavior of agents involved in the trans-
mission process. Models must capture this underlying heterosexual network
to predict how infections spread. Both the number of partners a person has
(the degree distribution of the graph) and the number of partners their part-
ners have (the joint-degree distribution of the graph) can impact this spread.
We use estimates (provided in the supporting information Table (3) and (4))
of both the heterosexual degree and joint-degree distribution from the ongoing
New Orleans Check-it of young AAs sexual behavior study [11] to generate a
heterosexual network that resembles sexual activity of this sub population of
New Orleans. That is, we use the B2K algorithm [31] to preserve this joint-
degree distribution and to generate an ensemble of heterosexual networks which
reflects sexual partnership for our modeled New Orleans population.
The heterosexual partnerships are divided into long-term (primary) and
short-term (casual) relationships. The casual partners change after a time, rang-
ing from a few weeks to more than a year, while primary partners are maintained
throughout the simulation. When changing casual partnerships, the degree and
joint-degree distribution of this dynamic network are preserved.
We model Ct transmission as a discrete-time Monte Carlo stochastic event
on this dynamic network. The model is initialized to agree with the current New
Orleans Ct prevalence. We use sensitivity analysis to quantify the effectiveness
of different prevention and intervention scenarios, including screening men, no-
tification of partners, which includes partner treatment and partner screening
(contact tracing), condom-use, and rescreening.
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2. Materials and Methods
To be successful, a transmission model must accurately reflect what is hap-
pening in the real world, and the parameter values must be based on con-
temporary studies for the population being studied [32]. The data used for our
network was collected in 2016 by two research studies in New Orleans, LA. One,
a pilot study of community-based STI testing and treatment for AA men ages
15− 25 [11] and the other, a study of an Internet-based unintended pregnancy
prevention intervention for AA women ages 18−19 [33]. These two studies were
reviewed and approved by the Tulane University Institutional Review Board.
The 202 men and 414 women enrolled in these studies were asked for the num-
ber of different heterosexual partners they have had in the past three months
(for women) or two months (for men). Women were also asked to estimate how
many partners that their partners have had in the past two months.
The survey results were used to construct the bipartite heterosexual network
of Pm men and Pw women. Using the Check-it survey data for the number
of partners, and the number of partners of partners in the last three months
[11, 33], we used the B2K algorithm [31] to generate an ensemble of hetero-
sexual networks for our model. Boroojeni et al. [31] B2K algorithm preserves
the degree (number of partners) and joint-degree (number of partners of part-
ners) distribution of nodes (individuals) estimated from the survey data and
provided in the supporting information. The generated network for the sexu-
ally active population preserves the distribution for the number of partners that
men and women have had in the past three months. The network also preserves
the distribution for the number of partners of their partners (the joint-degree
distribution) [31].
Each node i in the network represents a person, denoted by the index i,
and each edge eij represents sexual partnership between two nodes i and j on
that day. The underlying network for the sexually active population is weighted,
where the weight 0 < wij ≤ 1 for edge eij is the probability, of sexual act between
partners i and j on any specific day. The simulation network is dynamic and
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changes each day. For example, if wij = 1/7, these two partners engage in a
sexual act, on average, once a week, and the edge between nodes i and j is
present, on average, once every seven days. This is implemented in the model
as a stochastic process, the edge eij will exist (turn on) with probability wij.
The structure of the underlying weighted network changes every T days when
people change their casual partnerships. The updated underlying network with
the new casual partners has the same degree and joint-degree distributions as
the original network. We assume that every man has one primary partnership
that is maintained for the entire simulation; all other partnerships are causal.
When defining the initial network, we select the primary partner for each man
as his female partner with the fewest number of partners, and within two years
of his age. To change the casual partners, we use the subgraph of primary
partnership -as initial sexual network- and B2K algorithm in [31] to generate
a set of networks, and then every T days we update the network by randomly
choosing one network from this set.
In our stochastic Susceptible–Infectious–Susceptible (SIS) model, a person i
is either infected with Ct, Ii(t), or susceptible to being infected, Si(t). During
the day t, an infected person, Ij(t), can infect any of their susceptible sexual
partners, Si(t). We define λij as the probability that Si(t) will be infected by
Ij(t) by the end of the day, Si(t)
λij
→ Ii(t + 1). Similarly, we define γj as the
probability that an infected person, Ij(t), will recover by the end of the day,
Ij(t)
γj
→ Sj(t+ 1).
2.1. Force of infection
The force of infection, λij(t), is the probability that a susceptible person Sj is
infected on day t by Ij . The infection transmission depends on the probability of
a sexual act between person i and j on a typical day, as defined by edge weight,
wij , in the model. We define βnc as the probability of transmission per act
when a condom is not used, and βc as the reduced probability of transmission
per act when a condom is used. The forces of infection between i and j for when
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condom is not used, λncij , and for when condom is used, λ
c
ij , are defined by
λncij =


βnc with probability wij
0 with probability 1− wij
, λcij =


βc with probability wij
0 with probability 1− wij
.
(1)
Consistent condom use approximately 98% effective in preventing Ct transmis-
sion when used correctly [34, 35, 36, 37]. This effectiveness is reduced to 85% if
the condom is incorrectly used [38]. There is very little quantitative data on cor-
rect condom use, and correlating consistent condom with long-term versus casual
partners. In the model we assumed that condom use is ǫ = 90% effective in pre-
venting the infection from being transmitted, that is, βc = (1− ǫ)βnc = 0.1βnc.
We assume that, the effectiveness of condom is independent of gender of donors
and recipient, that is, if βm2w and βw2m are defined as probability of transmis-
sion from men to women and from women to men, then in the case of condom
use these values will reduce by the same factor (1 − ǫ). We also assume that
condoms are used more often in casual (riskier) partnerships (κ of the time)
than in long-term partnerships.
2.2. Recovery from infection
The model accounts for infected people recovering through natural recovery
or after being treated with antibiotics. We assume that a fraction of the people
treated for infection returns to be retested to see if they have been reinfected.
We also assume that all infected people eventually recover and return to sus-
ceptible status, even when they have not been treated. In the model, the time
for natural (untreated) recovery has an exponential distribution with an
average time of infection of τn = 1/γn days, and the duration of infection for
an individual is a random number from this distribution.
However, some infected individuals become recovered through treatment
which is part on intervention program, explained in details in the next sub-
section.
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2.3. Intervention strategies
We assume that the treatment is 100%, and the time to recover after treat-
ment is a log-normal distribution with the parameters of τ t = 1/γt day and σ2 =
0.25. That is, the duration of infection for a treated infected person k is defined
by a random number chosen from a log-normal distribution, logN (τ t, 0.25),
rounded to the nearest day. In the model, if that number of days is smaller
than the duration remaining for naturally clearing the disease, then the shorter
time is used for the recovery period.
Each year, a fraction of the population is tested for Ct infection through a
routine medical exam (random screening), after observing symptoms, or after
being notified that one of their previous partners was infected.
Random Screening : We define random screening as testing for infection
when there are no compelling reasons to suspect a person is infected. For
example, random screening might be part of a routine physical exam and is an
effective mitigation policy to identify asymptomatic infections. We assume that
the fraction σy% of people are randomly screened each year. Each individual is
screened with probability σd = 1 − (1 − σy)
1
365% each day. It is relatively rare
for the Ct screening test to give a false negative result, and in the model, we
assume that screening is 100% accurate.
Notification of Partners: We assume that an infected person encourages
some of their partners to be treated or tested for infection. We define θn as
the fraction of their partners who notified, which θt fraction of these notified
partners follow treatment, and the rest (θs = 1−θt fraction of notified partners)
test for the infection.
Therefore, a notified partner is the partner of an infected person who seeks
treatment or testing as a direct result of the screening. We can divide all partners
of person as follow:
(1) Partner Treatment: θnθt fraction of all partners that are notified and
treated, without first testing for infection.
(2) Partner Screening: θnθs fraction of all partners are notified and screened
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for infection and then start treatment if they are infected.
(3) Do nothing: 1−θn = 1−θnθt−θnθs fraction are neither tested nor treated.
The model includes a time-lag of τN days between the day a person is found
to be infected, and the day their partners are notified and take action.
Rescreening : A common practice in disease control is rescreening. People
found to be infected are treated and asked to return after a short period to be
tested again for infection. We assume that a fraction, σr, of the treated people
return for retesting τR days after treatment.
2.4. Model initialization
We initialize our model based on estimates for the current Ct epidemic in
New Orleans at the time the Ct prevalence was i0. The initially infected people
are not randomly distributed in an otherwise susceptible population. They
are distributed as they would be as part of an emerging epidemic that started
sometime in the past. We call these initial conditions balanced because when
the simulation starts, the infected and susceptible populations, along with the
duration of infection, are in balance with the distributions for an emerging
epidemic [39]. When the initial conditions are not balanced, then there is usually
a rapid (nonphysical) initial transient of infections that quickly dies out as the
infected and susceptible populations relax to a realistic infection network.
To define the balanced initial conditions, we start an epidemic in the past
by randomly infecting a few high degree individuals. We then advance the
simulation until the epidemic grows to the prevalence of i0. We then reset the
time clock to zero and use this distribution of infected people, complete with
their current infection timetable, as our initial conditions. Because these are
stochastic simulations, when doing an ensemble of simulations, we reinitialize
each simulation by seeding different initial infected individuals. Fig 1 illustrates
the typical progression of the epidemic to reach the current Ct prevalence of 10%
in sexually active men and 12% women in the 15−25 year-old New Orleans AA
community [11]. These estimates are based on the current Check it survey data
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Figure 1: Prevalence increases to reach the current quasi-stationary state: About
11% of total population are infected at the quasi-stationary state for the baseline model
parameters. The standard deviation of the prevalence is approximately 1%. This is in good
agreement with the current prevalence in New Orleans 15-25 year-old AA population. The
light areas are the result for 50 different stochastic simulations and the dark curve is the mean
value of those simulations.
of approximately 1084 AAs in New Orleans and have a standard error of about
1%.
The numerical simulations comparing the different mitigation strategies all
start at this endemic stochastic equilibrium.
3. Result
Each simulation is a single realization of a stochastic epidemic on one of an
ensemble of heterosexual networks that share the same joint-degree distribu-
tion. In our investigations, we have found that the qualitative trends for the
predictions as a function of these assumptions are insensitive to the details of
networks with the same joint-degree distribution. We compared these trends for
the predicted impact of increased random screening, infected partner treatment
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and screening, and rescreening of treated individuals on the prevalence of Ct
infection. All of the simulations start at a balanced equilibrium obtained with
the model baseline parameters in Table 1, unless stated otherwise.
In screening intervention, we assume that the day of screening is the day that
an infected person found through screening starts treatment, that is, getting
the result and starting treatment happens on the same day. We assume that
a treated person does not change his/her behavior. That is the treated person
regular sexual acts with partners and may infect susceptible partners during the
treatment period with the same probability of transmission for when natural
recovery. Once started, the interventions maintained as the solution approaches
a new quasi-stationary state corresponding to implemented intervention.
3.1. Sensitivity analysis
Table 2 gives the relative sensitivity indices for the change in the mean
values of the prevalence Pr with respect to the model parameters at the baseline
parameter values, SPrp . If the parameter P changes by x%, then Pr will change
by xSPrp %.
The prevalence is most sensitive to the fraction of time condom used, κ,
closely followed by uncertainty in the estimate of infection period in the absence
of treatment, 1/γn, and then the probability of transmission per sexual act,
βm2w and βw2m. Variation in other model parameters had a minor impact on
the model outcomes in the sensitivity analysis (≤ 1% ).
3.2. Random screening
To determine the effectiveness of increasing the number of men screened for
Ct per year, we compare the quasi-stationary state prevalence by varying the
fraction of men who are randomly screened each year, σmy . The current screening
rate for young men for Ct in high prevalence areas, like New Orleans, is low.
This scenario can estimate the cost-effectiveness of increased screening of young
men on the Ct prevalence in women [43, 44]. Fig 2 shows a reduction in the
overall Ct prevalence as the number of men randomly screened for Ct increases
11
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Figure 2: Quasi-stationary state prevalence of the population versus the fraction
of men are screened each year (All other parameters are defined as in Table 1): the circles
are the average of 50 different stochastic simulations, and the error bars are 95% confidence
intervals. Screening men randomly by 50% reduces prevalence by 7% (SI = 3.5%), which is
not effective enough to implement as a sole intervention.
from 0 to 50%, 0 ≤ σmy ≤ 0.5. The least-square linear fit suggests that the
quasi-stationary state Ct prevalence will decrease by 1.4% for every additional
10% of the men screened during a year (SI = 6.5%). Though a drop of seven
percent in prevalence is an admirable decrease, increased screening alone would
not be sufficient to control Ct. In this simulation, the casual partners of men
change every 60 days.
3.3. Notification of partners
The scenario of notifying partners quantifies the impact of giving an infected
person’s partners a chance to be tested and treated. As we mentioned before,
the fraction θn of an infected person’s partners are notified about infection. We
assume that some of these partners are treated, and others are screened for
infection.
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Figure 3: Quasi-stationary state prevalence of the population versus the fraction
of partners are notified for partner treatment only scenario (θt = 1): The circles are
the mean of 50 different stochastic simulations and error bars are 95% confidence intervals.
Partner treatment is only mildly effective, and the prevalence remains high (8%), even when
all the partners of treated people are treated.
3.3.1. Partner treatment only
In partner-treatment, we assume when someone is found to be infected, then
a fraction θn of their partners are notified, and then all of the notified partners
seek treatment without testing; that is, θt = 1. The Fig 3 shows the impact
of partner treatment for different values of partner notification values changing
from θn = 0 to θn = 1. The least-square linear fit suggests that the quasi-
stationary state Ct prevalence decreases by 0.07 for every 10% increment in the
fraction of notified partners seeking treatment. In this simulation, the casual
partners of men change every 60 days.
3.3.2. Partner screening only
To quantify the impact of screening the partners of an infected person, where
partners are tested and then treated if they are infected. We assume that all
notified partners of an infected person are screened; that is, θs = 1. Fig 4 shows
the impact as θn varies from 0 to 1 for the cases where the casual partners of
the men change, on average, every 60 days (black line), every year (blue curve),
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Figure 4: Quasi-stationary state prevalence of the population versus the fraction
of partners are notified for partner screening only scenario (θs = 1): All other pa-
rameters are at the baseline values in Table 1). The figure illustrates how the effectiveness
of partner notification increases as casual partners are changed less often from every 60 days
(black line), every year (blue curve), and every two years (red curve). The circles are the
mean of 50 different stochastic simulations and error bars are 95% confidence intervals. Part-
ner screening is more effective in situations where the casual partners less often.
and every two years (red curve), and Fig 5 is for the case men do not change
their casual partners (static network). The simulations predict the test and
treat partner notification is most effective when casual partnerships are longer
term. This is expected because when a partner is found to be infected, and
this partner’s other (long-term) partners are tested, then the contact tracing
is a branching process and is more likely to identify and treat the underlying
infected sexual network. The resulting nonlinear effect is evident in the logistic-
shaped curve θn when the casual-partners change less often.
Partner treatment and screening
Some of the notified partners will seek treatment without testing, and some
will allow themselves to be tested before being treated. We quantify the effec-
tiveness of this mixture of the two previous scenarios. We let the fraction of
notified partners, θn, range between 0.10 and 0.80. We also vary the fraction
of these notified partners who seek just treatment, θt. In these simulations,
θs = 1− θt of the population is screened for infection each year, and the casual
partners are updated every two years.
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Figure 5: Quasi-stationary state prevalence of the population versus the fraction
of partners are notified when all notified partners first follow screening and treat-
ment if infected i.e θs = 1 for static network (All other parameters are defined as in
Table 1): the circles are the mean of 50 different stochastic simulations and error bars are
95% confidence intervals. Partner screening approach is highly effective when θn is big enough,
that is, when θn ≥ 0.4 and θs = 1, the Ct prevalence rapidly decays to zero.
When few partners are notified and take action (θn is small), then partner
treatment and partner screening have almost the same impact on controlling the
prevalence. For example, for θn = 0.10, 0.20, the prevalence versus θt = 1 − θs
is flat; that is, there is no difference between cases if partners follow treatment
without testing or first test and then treat if infected, Fig 6.
As θn increases the partner screening becomes a highly successful mitigation
policy. Consider the case when half of the partners are notified and take action,
θn = 0.5, and half of them are screened for infection, θs = 0.5, and the other half
are treated without testing, θt = 0.5. That is, half of an infected person’s part-
ners do nothing, the fraction θnθt = 0.5×0.5 = 0.25 are treated without testing
for infection, and the fraction θnθs = 0.5 × 0.5 = 0.25 are tested and treated
if found infected. If any of the tested notified partners of the infected person
are found to be infected, their partners are then notified, and the cycle repeats
to spread out and identify more infected people. This conditional percolation
15
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Figure 6: Prevalence at quasi-stationary state increases when the fraction of
partners notified are treated and not tested (All other parameters are defined as in
Table 1): every curve is the mean of 50 different stochastic simulations. When only a few
partners of an infected person are notified, θn is small, then partner treatment and partner
screening have a similar small impact on Ct prevalence. When more partners of infected people
take action, θn increases, then the partner screening strategy is more effective in controlling
the infection.
of screening through the sexual network is why this policy is so effective. In
this case, the prevalence reduction is 6%. Thus when compared with all notified
partners following treatment without testing, θt = 1, which reduces the preva-
lence by only 1%, conditional percolation is more effective. But compared to
all notified partners following test and treat if necessary, θs = 1, which reduces
the prevalence by 11%, this combined scenario is not the one to select, Fig 6.
3.4. Rescreening
The rescreening scenario quantifies the effectiveness of different time-lags for
rescreening and quantifies the impact of rescreening on the prevalence of Ct.
Interval for rescreening
People who are found to be infected are more likely to be reinfected in the
future. Repeated Ct infection can be the result of sexual activity with a new
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Figure 7: Truncated cumulative probability distribution of time between treatment
and reinfection with Ct: fifty different curves from 50 stochastic simulations and 95%
confidence interval are shown in this figure. About 25% of the treated people are again
infected after 100 days. This increases to about 45% are reinfected after almost a year.
partner, or being reinfected from an existing infected partner. It makes sense to
ask the infected people who were treated to return in a few months for retesting.
We use the model to compare the rates of reinfection to help optimize the time,
τr, from treatment to rescreening.
The time τr between treatment and rescreening should be long enough so
that it is likely that the person would be reinfected if one of their partners
is still infected. If τr is too long, then a reinfected person could infect others.
The current CDC guidelines recommend that people are rescreened for infection
three months after treatment [45]. Past studies have observed that about 25%
of the rescreened people are again found to be infected by three months.
We plot the cumulative distribution of time between screening and reinfec-
tion events in Fig 7. The Figure demonstrates that our model also predicts that
about 25% of treated individuals are again infected after 100 days. The model
predicts that the Ct prevalence of the treated population exceeds the prevalence
for the whole population after two months and suggests that the CDC guidelines
for rescreening could be shortened slightly.
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Figure 8: Quasi-stationary state prevalence of population versus the fraction of
treated people who come back for screening, σr (All other parameters are defined as
in Table 1): the circles are the mean of 50 different stochastic simulations and error bars are
95% confidence intervals. Rescreening all the infected people reduces the prevalence by 2%.
3.4.1. Rescreening rate
Typically, only about 10% (σr = 0.1) of screened individuals return for re-
screening. To understand if increasing the rate that people return for rescreen-
ing would have a significant impact on Ct prevalence, we varied the fraction of
treated individuals who return for rescreening at 100 days after being treated.
The Fig 8 quantifies the prevalence of Ct at quasi-stationary state dependent
on rescreening rate σr: there is a negative correlation between prevalence at
quasi-stationary state and σr when σr fraction of screened individuals returns
for rescreening, if σr fraction of screened individuals follow screening again then
the prevalence reduces roughly by 0.02σr (SI = 2%). We observe that this
rescreening result is insensitive to partner change in the network.
4. Discussion
Using a heterosexual behavior survey and Ct prevalence data for the sexually
active young AA population in New Orleans, we created an agent-based dynamic
network model to understand how the infection spreads and what mitigation
approaches can slow it down. In the model, men and women are represented by
the network nodes, and the sexual partners are characterized by edges between
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the nodes. The edges between partners in the network dynamically appear and
disappear each day, depending on if the individuals engage in sex on that day.
The partners of men are divided into primary and casual ones, and their casual
partners are changing over time. One novel property of our model is that the
joint-degree distribution of the network- which captures the correlation of an
individual’s risk (their number of partners) with their partner’s risk (number of
partners of their partners)- is preserved while changing casual partners. That
is, in whole time frame of the simulation and in spite of changing the sexual
network, we are capturing the information collected from data.
There is a wide range of reported values for the probability of transmission
per sexual contact, ranging from from 0.04 to 0.16 [27, 28, 23, 24, 25, 26]. We
calibrated this parameter to the current prevalence of Ct among adolescents and
young adult AAs in New Orleans [11]. In our model, we defined the probability
of transmission from man to woman as 0.1 per contact, and from woman to man
is 0.04 per contact.
We use this model to quantify the impact of increasing screening of men
for infection, notification of partners, and rescreening of treated individuals on
reducing Ct prevalence. We observed that increasing Ct screening of men has
a modest impact on reducing Ct prevalence in the young adult AAs in New
Orleans, Fig 2. Starting at a baseline of 11% prevalence under the assumption
that 45% of the women are being screened each year for Ct, then increasing the
screening of men from 0% to 50% reduces the overall Ct prevalence to 8%. Our
observation that partner positivity is insensitive to screening is consistent with
previous studies [22].
In evaluating the effectiveness of partner-notification, we assumed some of
the partners of an infected person would seek treatment (without testing) or
be screened (tested and treated) for infection. We observed that if most of the
notified partners are treated, without testing, then this mitigation has only a
modest impact on Ct prevalence. This practice, although common in disease
control today, is not as effective as partner screening. When individuals change
their partner less frequently, and the partners of an infected person were tested
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before treatment, there was a tipping point where partner screening would bring
the epidemic under control. For example, when casual partners do not change
very often, then when over 40% of notified partners of all the infected people are
screened for infection, the Ct prevalence rapidly decreased to very low levels,
Fig 5. This critical threshold represents the partner screening level, where a
contact tracing tree can spread through the heterosexual network to identify
and treat most of the infected people. Our model indicates that this is by far
the most effective approach for bringing the epidemic under control.
However, partner screening is more expensive than partner treatment. The
partner treatment and screening suggests that when the fraction of partners
took action (θn is small), then partner screening may not be a good strategy
compared to partner treatment. But if a large enough fraction of partners is
notified, then it is better to test and treat (partner screening) to control the
spread of Ct effectively. These results of the impact of notification of partner
are close to results from [30] who found for Ct, contact tracing is less effective
at lower percentages when partners are treated, but with increasing levels of
contact tracing it will be a highly effective intervention strategy.
In rescreening, infected individuals return for testing a few months after
being treated. We used the model to estimate the probability that a treated
person would be reinfected as a function of the time since they were treated.
The CDC guidelines recommend that treated people return for screening three
months after treatment. We observed that for the case of 13% infected popu-
lation, about 25% of the treated population were reinfected three months after
treatment. Previously infected people are more likely to be infected again than
the average person. Although the rescreening has only a small impact on the
overall Ct prevalence, it is an effective way of identifying reinfection. Even
though there is a high chance of reinfection when the individual’s behavior does
not change, we do not observe an effective impact on the prevalence of Ct by
monitoring infected individuals. The rescreening program has a trend similar
to screening, and none of them are effective as sole intervention because they
are not able to find the chain of infection like partner screening. On the other
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hand, the sensitivity of prevalence to rescreening is less than that of screening,
indicating the fact that for a limited budget, the idea of finding more people
to screen, random screening, is more effective than frequent screening for fewer
people.
Although our model takes into account different important factors for STI
transmission and can be used to assess the relative impact of different mitigation,
it is still too simplistic to be used for quantitative predictions. One of the most
important behaviors to capture in an STI model is how often condoms are used
in long-term and casual partnerships. Although our model includes condom use,
it does not account for behavior changes, such as increased condom use after
being treated for the infection. Our future research will improve the model so
we can better quantify the impact of counseling and behavioral changes such as
increasing condom use or partner notification rates. We are expanding our data
analysis to include a cost-benefit analysis and estimate the averted PID cases
in women.
Our bipartite heterosexual network model was constructed based on the
correlations between the number of partners a person has and the number of
partners their partners have. For our future work, we will extend our assorta-
tive mixing model to improve our assumptions where sexual partnerships are
better characterized by their ages, ethnicity, social groups, economic status, and
geographic location. We will focus on validating the model predictions and iden-
tifying which trends and quantities can and cannot be predicted within limits
of the model uncertainty. Our preliminary studies indicate that the qualitative
findings of this paper are relatively insensitive to adding these additional mixing
constraints. Although the model is still too simplest to directly guide mitigation
efforts, the qualitative trends predicted by these simulations can be useful in
designing studies to quantify the effectiveness of different mitigation efforts.
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Tables 3 and 4 define the joint-degree distribution for the number of partners
of partners for men and women in the population used in this study. The element
pij of Table 4 is the fraction of edges between men with i partners and women
with j partners. The fraction of men with i partners is the sum of the ith
row divided by i, and the fraction of women with j partners is the sum of
the jth column divided by value j. The algorithm in [31] guarantees that the
joint-degree distribution of generated network is consistent with the Kissinger
et al. Check It study of the behavior of 15− 25 year-old sexually active African
American men and women in New Orleans [11], Table 3.
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Table 1: Parameters definition and value: the model parameters describing the trans-
mission of Ct infection, as well as recovery associated with natural recovery, screening, and
notification of partners were obtained from the literature [11, 40, 16, 41], but other parameters
are calibrated to biological, behavioral, and epidemiological data from general heterosexual
population resides in New Orleans. Probability of transmission per act is calibrated to a
baseline prevalence of 12% among women and 10% among men.
Parameter Description Baseline Unit Reference
∆t Time step 1 day –
Pm(Pw) Population of men (women) 2000(3000) people Assumed
βm2w Probability of transmission per act from men to
women
0.10 – Calibrated
βw2m Probability of transmission per act from women to
men
0.04 – Calibrated
κ Fraction of times that condoms are used during sex 0.58 – [11]
ǫ Condom effectiveness 0.90 – Assumed
1/γn Average time to recover without treatment 365 days [42, 16]
1/γt Average time to recover with treatment 7 days [41]
σmy Fraction of men randomly screened per year 0.05 – [11]
σwy Fraction of women randomly screened per year 0.45 – [11]
σr Fraction of infected people return for rescreening 0.10 – Assumed
Sensitivity Screening sensitivity 100% – Assumed
θn Fraction of the partners of an infected person who are
notified and do test or treated for infection
0.26 – [11]
θt Fraction of notified partners of an infected person who
are treated without testing
0.75 – [11]
θs Fraction of notified partners of an infected person who
are tested and treated for infection
0.25 – [11]
τN Time lag of partner notification 5 days Assumed
τR Time lag of re-screening 100 days Calculated
T Time period for casual partner change 60 days Assumed
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Relative sensitivity index of prevalence Pr
Parameter p Baseline SPrp Parameter p Baseline S
Pr
p
κ 0.58 −2.47 1/γn 365 1.66
βw2m 0.04 1.03 βm2w 0.10 1.02
1/γt 7 −0.15 σr 0.10 −0.02
τR 100 −0.01 τN 5 −0.0569
Table 2: The sensitivity indexes of prevalence at quasi-steady state, Pr, with respect to
parameters of the model, at the baseline parameter values where Pr = 0.11. The most
sensitive parameter for the prevalence is the fraction of sexual acts condom used, κ. If condom
use increased by 10%, then the prevalence, Pr, would decrease by −24.7% = −2.47 × 10%.
The second most sensitive parameter is the natural recovery period, τn = 1/γn.
Table 3: Joint-degree Table of sample data for women participant in the last three months.
Number of Partners for Women Participants
1 2 3 4 5 6
1 197 46 16 4 0 3
2 56 34 11 2 2 0
3 28 23 3 4 3 5
4 9 30 10 0 0 1
5 2 2 2 0 0 0
Number of 6 3 1 1 1 4 0
Partners 7 0 2 1 0 0 1
for 8 1 0 0 0 0 0
Partners of 9 0 0 1 0 0 0
Women 10 0 1 0 0 0 0
Participants 11 0 0 0 1 0 0
12 0 0 0 0 1 1
13 0 1 0 0 0 0
16 1 0 0 0 0 1
21 0 0 1 0 0 0
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Table 4: The joint-degree probability distribution for heterosexual partnerships used in the
computer simulations. Men and women are assumed to have fewer than 21 and 6 partners,
respectively. The entry in the ith row and jth column is the fraction of partnership (edges)
between men who have i partners (degree i) and women who have j partners (degree j).
Degree
of men
Degree of
women
1 2 3 4 5 6
1 0.3775 0 0 0 0 0
2 0.1880 0.0205 0 0 0 0
3 0.0988 0.0396 0.0162 0.0033 0 0
4 0.0833 0.0734 0.0285 0.0087 0.0034 0.0010
5 0.0313 0.0264 0.0162 0.0083 0.0037 0.0014
6 0.0207 0.0209 0.0134 0.0066 0.0025 0.0003
7 0.0150 0.0167 0.0107 0.0046 0.0008 0
8 0.0116 0.0135 0.0082 0.0026 0 0
9 0.0093 0.0110 0.0061 0.0008 0 0
10 0.0075 0.0090 0.0043 0 0 0
11 0.0061 0.0074 0.0027 0 0 0
12 0.0050 0.0062 0.0014 0 0 0
13 0.0042 0.0053 0.0005 0 0 0
14 0.0034 0.0045 0 0 0 0
15 0.0027 0.0037 0 0 0 0
16 0.0021 0.0031 0 0 0 0
17 0.0016 0.0027 0 0 0 0
18 0.0012 0.0023 0 0 0 0
19 0.0009 0.0020 0 0 0 0
20 0.0007 0.0017 0 0 0 0
21 0.0059 0.0070 0.020 0 0 0
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The Fig 9 is a visualization of a random sexual network of 5000 individuals
generated using data in Tables 3 and 4 and the algorithm in [31].
Figure 9: Visualization of generated heterosexual network of 5000 individuals: Or-
ange family color is the giant component and green parts are the other components of the
network. The size of each node is related to its degree, more partners, bigger the node.
In the Table 5, we report confidence intervals of prevalence at quasi-
stationary state for all population with respect to some of the screening pa-
rameter values, some of the partner notification parameter values when θt = 1,
and some of the rescreening parameter values.
Fig 10 shows the impact of men screening on prevalence among men and
women separately for the case where the network is static. We observe that
screening intervention is insensitive to how often the casual partners change.
Fig. 11 shows the impact of partner treatment on prevalence among men and
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Table 5: The 95% confidence intervals for the fraction of men screened per year (σmy ), the
fraction of partners notified when all follow treatment (θn when θt = 1), and the fraction of
people return for screening (σr).
Parameter
Value
0 0.2 0.4 0.6 0.8 1
95% CI for σmy [0.1256, 0.1294] [0.1192, 0.1227] [0.1038, 0.1092] [0.0983, 0.1076] [0.0844, 0.0919] [0.0768, 0.0878]
95% CI for θn
when θt = 1
[0.1307, 0.1424] [0.1319, 0.1383] [0.1181, 0.1222] [0.1041, 0.1075] [0.0837, 0.0895] [0.0726, 0.0766]
95% CI for σr [0.1270, 0.1306] [0.1225, 0.1265] [0.1186, 0.1230] [0.1181, 0.1224] [0.1052, 0.1146] [0.1097, 0.1145]
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Figure 10: Prevalence of men and women versus fraction of men screened each
year.
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Figure 11: Prevalence of men and women versus the fraction of the partners of
treated people who are treated after being notified.
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Figure 12: Prevalence of men and women versus the fraction of the partners of
treated people who are tested before [H] treatment.
women separately for the case where the network is static. We observe that
partner treatment intervention is insensitive to partner change in time. When
the network is static, the logistic curve steepens to become a threshold condition
(tipping point) where at θn ≈ 0.4 the epidemic can be brought under control.
The tipping point results from the partner screening percolating through the
sexual network to identify the infected individuals, Fig 12.
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